HIF-1α: A key survival factor for serum-deprived prostate cancer cells

BACKGROUND Hypoxia‐inducible factor‐1α (HIF‐1α) is commonly overexpressed in prostate cancer (PCa) cells. As PCa cells are known to survive serum deprivation, we investigated the effect of prolonged serum deprivation on HIF‐1α expression, and the function of HIF‐1α in regulating the survival of norm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Prostate 2008-09, Vol.68 (13), p.1405-1415
Hauptverfasser: Thomas, Rusha, Kim, Myoung H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1415
container_issue 13
container_start_page 1405
container_title The Prostate
container_volume 68
creator Thomas, Rusha
Kim, Myoung H.
description BACKGROUND Hypoxia‐inducible factor‐1α (HIF‐1α) is commonly overexpressed in prostate cancer (PCa) cells. As PCa cells are known to survive serum deprivation, we investigated the effect of prolonged serum deprivation on HIF‐1α expression, and the function of HIF‐1α in regulating the survival of normoxic serum‐deprived PCa cells. METHODS HIF‐1α protein was assessed by immunoblots. Cell viability and proliferation were assessed by trypan blue assay and flow cytometric analysis. Transcriptional activity was assessed by luciferase reporter assay and RT‐PCR. HIF‐1α expression was suppressed with siRNA. Activities of HIF‐1α‐target genes were inhibited with neutralizing antibody. RESULTS Prolonged serum deprivation is a potent inducer of HIF‐1α in PC‐3 and LNCaP PCa cells, despite normal oxygen conditions. In contrast, cells grown in the presence of serum did not show HIF‐1α protein accumulation. Moreover, HIF‐1α protein increase during serum deprivation correlated with increased cell survival, while suppression of HIF‐1α expression significantly decreased PCa cell viability. Our results further demonstrate that HIF‐1α protein increase is due to increased HIF‐1α protein synthesis. First, there was no significant increase in HIF‐1α mRNA. Secondly, cycloheximide, a protein synthesis inhibitor, prevented HIF‐1α protein increase in serum‐deprived PCa cells. Moreover, the expression of HIF‐1α‐target genes, VEGF and IGF‐2, was concomitantly increased in serum‐deprived PCa cells, while suppression of HIF‐1α expression significantly inhibited their induction. Furthermore, inhibition of IGF‐2 activity resulted in a significant decline in PCa cell survival. CONCLUSION PCa cells counteract the stress of prolonged serum deprivation by upregulating HIF‐1α protein which increases IGF‐2 expression to promote cell survival. Prostate 68: 1405–1415, 2008. © 2008 Wiley‐Liss, Inc.
doi_str_mv 10.1002/pros.20808
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2593855</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69441755</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4568-9b90f46613e46eed6629da79227a2a0a1b279c45f8933814a7babb33839b7c3b3</originalsourceid><addsrcrecordid>eNp9kMlOwzAQhi0EgrJceACUEwekFG-xYw5IFUuLVAFiEYiL5SQTCKRNsZNCH4sX4ZlwadkuHCxb8jffzPwIbRLcJhjT3ZGtXJviGMcLqEWwkiHGPFpELUwlDjlhcgWtOveIsccxXUYrJI4EkyRqoW7v5Dgk7297QSd4gkngGjsuxqYMcpPWlQ1yfxzYZhBmMLLFGLJg2q42NQSpGaZggxTK0q2jpdyUDjbm9xq6Pj66OuiF_bPuyUGnH6Y8EnGoEoVzLgRhwAVAJgRVmZGKUmmowYYkVCqP5rFiLCbcyMQkiX8ylciUJWwN7c-8oyYZQJbCsLam1H60gbETXZlC__0ZFg_6vhprGikWR5EXbM8FtnpuwNV6ULjpCmYIVeO0UJwT-QnuzMDU7-ss5N9NCNbT3PU0CP2Zu4e3fo_1g86D9gCZAS9FCZN_VPr84uzySxrOagpXw-t3jbFPWkgmI31z2tX9q0N-R89P9S37AMrSngg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69441755</pqid></control><display><type>article</type><title>HIF-1α: A key survival factor for serum-deprived prostate cancer cells</title><source>MEDLINE</source><source>Wiley Journals</source><creator>Thomas, Rusha ; Kim, Myoung H.</creator><creatorcontrib>Thomas, Rusha ; Kim, Myoung H.</creatorcontrib><description>BACKGROUND Hypoxia‐inducible factor‐1α (HIF‐1α) is commonly overexpressed in prostate cancer (PCa) cells. As PCa cells are known to survive serum deprivation, we investigated the effect of prolonged serum deprivation on HIF‐1α expression, and the function of HIF‐1α in regulating the survival of normoxic serum‐deprived PCa cells. METHODS HIF‐1α protein was assessed by immunoblots. Cell viability and proliferation were assessed by trypan blue assay and flow cytometric analysis. Transcriptional activity was assessed by luciferase reporter assay and RT‐PCR. HIF‐1α expression was suppressed with siRNA. Activities of HIF‐1α‐target genes were inhibited with neutralizing antibody. RESULTS Prolonged serum deprivation is a potent inducer of HIF‐1α in PC‐3 and LNCaP PCa cells, despite normal oxygen conditions. In contrast, cells grown in the presence of serum did not show HIF‐1α protein accumulation. Moreover, HIF‐1α protein increase during serum deprivation correlated with increased cell survival, while suppression of HIF‐1α expression significantly decreased PCa cell viability. Our results further demonstrate that HIF‐1α protein increase is due to increased HIF‐1α protein synthesis. First, there was no significant increase in HIF‐1α mRNA. Secondly, cycloheximide, a protein synthesis inhibitor, prevented HIF‐1α protein increase in serum‐deprived PCa cells. Moreover, the expression of HIF‐1α‐target genes, VEGF and IGF‐2, was concomitantly increased in serum‐deprived PCa cells, while suppression of HIF‐1α expression significantly inhibited their induction. Furthermore, inhibition of IGF‐2 activity resulted in a significant decline in PCa cell survival. CONCLUSION PCa cells counteract the stress of prolonged serum deprivation by upregulating HIF‐1α protein which increases IGF‐2 expression to promote cell survival. Prostate 68: 1405–1415, 2008. © 2008 Wiley‐Liss, Inc.</description><identifier>ISSN: 0270-4137</identifier><identifier>EISSN: 1097-0045</identifier><identifier>DOI: 10.1002/pros.20808</identifier><identifier>PMID: 18563715</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adenocarcinoma - metabolism ; Adenocarcinoma - pathology ; Antibodies - pharmacology ; Biomarkers, Tumor - metabolism ; Cell Line, Tumor ; Cell Proliferation ; Cell Survival - physiology ; Cycloheximide - pharmacology ; HIF-1α ; Humans ; Hypoxia - metabolism ; Hypoxia-Inducible Factor 1, alpha Subunit - genetics ; Hypoxia-Inducible Factor 1, alpha Subunit - metabolism ; IGF-2 ; Insulin-Like Growth Factor II - immunology ; Insulin-Like Growth Factor II - metabolism ; Male ; prostate cancer ; Prostatic Neoplasms - metabolism ; Prostatic Neoplasms - pathology ; Protein Synthesis Inhibitors - pharmacology ; RNA, Small Interfering - pharmacology ; Serum Albumin, Bovine - pharmacology ; serum deprivation ; survival ; Up-Regulation ; Vascular Endothelial Growth Factor A - metabolism</subject><ispartof>The Prostate, 2008-09, Vol.68 (13), p.1405-1415</ispartof><rights>Copyright © 2008 Wiley‐Liss, Inc.</rights><rights>(c) 2008 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4568-9b90f46613e46eed6629da79227a2a0a1b279c45f8933814a7babb33839b7c3b3</citedby><cites>FETCH-LOGICAL-c4568-9b90f46613e46eed6629da79227a2a0a1b279c45f8933814a7babb33839b7c3b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpros.20808$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpros.20808$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18563715$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thomas, Rusha</creatorcontrib><creatorcontrib>Kim, Myoung H.</creatorcontrib><title>HIF-1α: A key survival factor for serum-deprived prostate cancer cells</title><title>The Prostate</title><addtitle>Prostate</addtitle><description>BACKGROUND Hypoxia‐inducible factor‐1α (HIF‐1α) is commonly overexpressed in prostate cancer (PCa) cells. As PCa cells are known to survive serum deprivation, we investigated the effect of prolonged serum deprivation on HIF‐1α expression, and the function of HIF‐1α in regulating the survival of normoxic serum‐deprived PCa cells. METHODS HIF‐1α protein was assessed by immunoblots. Cell viability and proliferation were assessed by trypan blue assay and flow cytometric analysis. Transcriptional activity was assessed by luciferase reporter assay and RT‐PCR. HIF‐1α expression was suppressed with siRNA. Activities of HIF‐1α‐target genes were inhibited with neutralizing antibody. RESULTS Prolonged serum deprivation is a potent inducer of HIF‐1α in PC‐3 and LNCaP PCa cells, despite normal oxygen conditions. In contrast, cells grown in the presence of serum did not show HIF‐1α protein accumulation. Moreover, HIF‐1α protein increase during serum deprivation correlated with increased cell survival, while suppression of HIF‐1α expression significantly decreased PCa cell viability. Our results further demonstrate that HIF‐1α protein increase is due to increased HIF‐1α protein synthesis. First, there was no significant increase in HIF‐1α mRNA. Secondly, cycloheximide, a protein synthesis inhibitor, prevented HIF‐1α protein increase in serum‐deprived PCa cells. Moreover, the expression of HIF‐1α‐target genes, VEGF and IGF‐2, was concomitantly increased in serum‐deprived PCa cells, while suppression of HIF‐1α expression significantly inhibited their induction. Furthermore, inhibition of IGF‐2 activity resulted in a significant decline in PCa cell survival. CONCLUSION PCa cells counteract the stress of prolonged serum deprivation by upregulating HIF‐1α protein which increases IGF‐2 expression to promote cell survival. Prostate 68: 1405–1415, 2008. © 2008 Wiley‐Liss, Inc.</description><subject>Adenocarcinoma - metabolism</subject><subject>Adenocarcinoma - pathology</subject><subject>Antibodies - pharmacology</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Cell Survival - physiology</subject><subject>Cycloheximide - pharmacology</subject><subject>HIF-1α</subject><subject>Humans</subject><subject>Hypoxia - metabolism</subject><subject>Hypoxia-Inducible Factor 1, alpha Subunit - genetics</subject><subject>Hypoxia-Inducible Factor 1, alpha Subunit - metabolism</subject><subject>IGF-2</subject><subject>Insulin-Like Growth Factor II - immunology</subject><subject>Insulin-Like Growth Factor II - metabolism</subject><subject>Male</subject><subject>prostate cancer</subject><subject>Prostatic Neoplasms - metabolism</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Protein Synthesis Inhibitors - pharmacology</subject><subject>RNA, Small Interfering - pharmacology</subject><subject>Serum Albumin, Bovine - pharmacology</subject><subject>serum deprivation</subject><subject>survival</subject><subject>Up-Regulation</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><issn>0270-4137</issn><issn>1097-0045</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMlOwzAQhi0EgrJceACUEwekFG-xYw5IFUuLVAFiEYiL5SQTCKRNsZNCH4sX4ZlwadkuHCxb8jffzPwIbRLcJhjT3ZGtXJviGMcLqEWwkiHGPFpELUwlDjlhcgWtOveIsccxXUYrJI4EkyRqoW7v5Dgk7297QSd4gkngGjsuxqYMcpPWlQ1yfxzYZhBmMLLFGLJg2q42NQSpGaZggxTK0q2jpdyUDjbm9xq6Pj66OuiF_bPuyUGnH6Y8EnGoEoVzLgRhwAVAJgRVmZGKUmmowYYkVCqP5rFiLCbcyMQkiX8ylciUJWwN7c-8oyYZQJbCsLam1H60gbETXZlC__0ZFg_6vhprGikWR5EXbM8FtnpuwNV6ULjpCmYIVeO0UJwT-QnuzMDU7-ss5N9NCNbT3PU0CP2Zu4e3fo_1g86D9gCZAS9FCZN_VPr84uzySxrOagpXw-t3jbFPWkgmI31z2tX9q0N-R89P9S37AMrSngg</recordid><startdate>20080915</startdate><enddate>20080915</enddate><creator>Thomas, Rusha</creator><creator>Kim, Myoung H.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20080915</creationdate><title>HIF-1α: A key survival factor for serum-deprived prostate cancer cells</title><author>Thomas, Rusha ; Kim, Myoung H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4568-9b90f46613e46eed6629da79227a2a0a1b279c45f8933814a7babb33839b7c3b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adenocarcinoma - metabolism</topic><topic>Adenocarcinoma - pathology</topic><topic>Antibodies - pharmacology</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Cell Survival - physiology</topic><topic>Cycloheximide - pharmacology</topic><topic>HIF-1α</topic><topic>Humans</topic><topic>Hypoxia - metabolism</topic><topic>Hypoxia-Inducible Factor 1, alpha Subunit - genetics</topic><topic>Hypoxia-Inducible Factor 1, alpha Subunit - metabolism</topic><topic>IGF-2</topic><topic>Insulin-Like Growth Factor II - immunology</topic><topic>Insulin-Like Growth Factor II - metabolism</topic><topic>Male</topic><topic>prostate cancer</topic><topic>Prostatic Neoplasms - metabolism</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Protein Synthesis Inhibitors - pharmacology</topic><topic>RNA, Small Interfering - pharmacology</topic><topic>Serum Albumin, Bovine - pharmacology</topic><topic>serum deprivation</topic><topic>survival</topic><topic>Up-Regulation</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thomas, Rusha</creatorcontrib><creatorcontrib>Kim, Myoung H.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Prostate</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thomas, Rusha</au><au>Kim, Myoung H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HIF-1α: A key survival factor for serum-deprived prostate cancer cells</atitle><jtitle>The Prostate</jtitle><addtitle>Prostate</addtitle><date>2008-09-15</date><risdate>2008</risdate><volume>68</volume><issue>13</issue><spage>1405</spage><epage>1415</epage><pages>1405-1415</pages><issn>0270-4137</issn><eissn>1097-0045</eissn><abstract>BACKGROUND Hypoxia‐inducible factor‐1α (HIF‐1α) is commonly overexpressed in prostate cancer (PCa) cells. As PCa cells are known to survive serum deprivation, we investigated the effect of prolonged serum deprivation on HIF‐1α expression, and the function of HIF‐1α in regulating the survival of normoxic serum‐deprived PCa cells. METHODS HIF‐1α protein was assessed by immunoblots. Cell viability and proliferation were assessed by trypan blue assay and flow cytometric analysis. Transcriptional activity was assessed by luciferase reporter assay and RT‐PCR. HIF‐1α expression was suppressed with siRNA. Activities of HIF‐1α‐target genes were inhibited with neutralizing antibody. RESULTS Prolonged serum deprivation is a potent inducer of HIF‐1α in PC‐3 and LNCaP PCa cells, despite normal oxygen conditions. In contrast, cells grown in the presence of serum did not show HIF‐1α protein accumulation. Moreover, HIF‐1α protein increase during serum deprivation correlated with increased cell survival, while suppression of HIF‐1α expression significantly decreased PCa cell viability. Our results further demonstrate that HIF‐1α protein increase is due to increased HIF‐1α protein synthesis. First, there was no significant increase in HIF‐1α mRNA. Secondly, cycloheximide, a protein synthesis inhibitor, prevented HIF‐1α protein increase in serum‐deprived PCa cells. Moreover, the expression of HIF‐1α‐target genes, VEGF and IGF‐2, was concomitantly increased in serum‐deprived PCa cells, while suppression of HIF‐1α expression significantly inhibited their induction. Furthermore, inhibition of IGF‐2 activity resulted in a significant decline in PCa cell survival. CONCLUSION PCa cells counteract the stress of prolonged serum deprivation by upregulating HIF‐1α protein which increases IGF‐2 expression to promote cell survival. Prostate 68: 1405–1415, 2008. © 2008 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>18563715</pmid><doi>10.1002/pros.20808</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0270-4137
ispartof The Prostate, 2008-09, Vol.68 (13), p.1405-1415
issn 0270-4137
1097-0045
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2593855
source MEDLINE; Wiley Journals
subjects Adenocarcinoma - metabolism
Adenocarcinoma - pathology
Antibodies - pharmacology
Biomarkers, Tumor - metabolism
Cell Line, Tumor
Cell Proliferation
Cell Survival - physiology
Cycloheximide - pharmacology
HIF-1α
Humans
Hypoxia - metabolism
Hypoxia-Inducible Factor 1, alpha Subunit - genetics
Hypoxia-Inducible Factor 1, alpha Subunit - metabolism
IGF-2
Insulin-Like Growth Factor II - immunology
Insulin-Like Growth Factor II - metabolism
Male
prostate cancer
Prostatic Neoplasms - metabolism
Prostatic Neoplasms - pathology
Protein Synthesis Inhibitors - pharmacology
RNA, Small Interfering - pharmacology
Serum Albumin, Bovine - pharmacology
serum deprivation
survival
Up-Regulation
Vascular Endothelial Growth Factor A - metabolism
title HIF-1α: A key survival factor for serum-deprived prostate cancer cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T00%3A28%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HIF-1%CE%B1:%20A%20key%20survival%20factor%20for%20serum-deprived%20prostate%20cancer%20cells&rft.jtitle=The%20Prostate&rft.au=Thomas,%20Rusha&rft.date=2008-09-15&rft.volume=68&rft.issue=13&rft.spage=1405&rft.epage=1415&rft.pages=1405-1415&rft.issn=0270-4137&rft.eissn=1097-0045&rft_id=info:doi/10.1002/pros.20808&rft_dat=%3Cproquest_pubme%3E69441755%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69441755&rft_id=info:pmid/18563715&rfr_iscdi=true